๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A phase II study of phenesterin (NSC-104469)

โœ Scribed by Bennett, J. M. ;Frank, J. ;Sears, M. ;Lagakos, S. W. ;Horton, J. ;Colsky, J. ;Hall, T. C. ;,


Publisher
John Wiley and Sons
Year
1978
Tongue
English
Weight
327 KB
Volume
4
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

Phenesterin was evaluated in 222 patients with two different dosage regimens, one by daily treatment and the other with an intermittent schedule. Toxicity was moderate with both programs. The largest group of patients treated had breast cancer; they experienced a 10% response rate. Of interest was a higher percentage of responses in ovarian cancer (36%). An expanded study of patients with ovarian cancer would be of interest.


๐Ÿ“œ SIMILAR VOLUMES


Phase II study of hexamethylmelamine (NS
โœ W. L. Wilson; J. M. Schroeder; H. F. Bisel; R. Mrazek; R. P. Hummel ๐Ÿ“‚ Article ๐Ÿ“… 1969 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 407 KB
Phase I study of L-alanosine (NSC 15353)
โœ Michael A. Goldsmith; Takao Ohnuma; Melvin Spigelman; Ezra M. Greenspan; James F ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 234 KB ๐Ÿ‘ 1 views
Phase II study of high-dose tamoxifen (N
โœ Edward T. Creagan; James N. Ingle; David L. Ahmann; Stephanie J. Green ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 206 KB ๐Ÿ‘ 3 views

Seventeen patients with disseminated malignant melanoma received a daily oral regimen of tamoxifen, 100 mg/m2. All patients had prior chemotherapy and predominantly visceral involvement. None of the patients had an objective regression and most (71%) had progressive disease at the time of first reas